Identification and Prevention of Pelvic Floor Dysfunction in Gynecologic Cancer Survivors
Sponsor: Washington University School of Medicine
Terminated
Former PI left the institution so enrollment was closed early.
Other terminated trials from Washington University School of Medicine
- Extensive-stage Small Cell Lung Cancer · Phase PHASE2 · Aug 2025
- Schizophrenia · Phase PHASE1 · Jan 2025
- Systemic Lidocaine Improves Pain Control After Surgery by Attenuating the Systemic Inflammatory Response to Surgery · Phase PHASE4 · Dec 2024
- Recurrent Rectal Cancer · Phase NA · Nov 2024
- Small Cell Lung Carcinoma · Phase PHASE1 · Nov 2024
See all terminations from Washington University School of Medicine
Other Gynecologic Cancer trials with similar outcome
Listed as NCT05769062, this NA trial focuses on Gynecologic Cancer and remains terminated or withdrawn. Sponsored by Washington University School of Medicine, it has been updated 10 times since 2023, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
10 versions recorded-
Nov 2025 — Present [monthly]
Terminated NA
Status: Active Not Recruiting → Terminated
-
Sep 2025 — Nov 2025 [monthly]
Active Not Recruiting NA
-
Jul 2025 — Sep 2025 [monthly]
Active Not Recruiting NA
-
May 2025 — Jul 2025 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Sep 2024 — May 2025 [monthly]
Recruiting NA
▶ Show 5 earlier versions
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
Jul 2023 — Jul 2024 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Jun 2023 — Jul 2023 [monthly]
Not Yet Recruiting NA
-
May 2023 — Jun 2023 [monthly]
Not Yet Recruiting NA
-
Apr 2023 — May 2023 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Washington University School of Medicine
For direct contact, visit the study record on ClinicalTrials.gov .